SANPHAR / IPEVE announces entry into the market for autologous tilapia vaccines

SANPHAR / IPEVE is the first to offer bivalent autogenous vaccines for national tilapia farming.

Follow SANPHAR on YouTube

SANPHAR re-launched its YouTube channel. Have a look and follow us on YouTube

SANPHAR becomes part of SAN Group

Herzogenburg/Austria, September 1, 2020 – After selling Erber Group (Biomin, Romer Labs) to the Dutch group Royal DSM, Erich Erber founds a new company group, SAN Group. It comprises 200 employees on…

Prevention and biosecurity are ways for sustainable animal protein production with rational use of antibiotics

Farm biosecurity and prevention are among the most important measures to be intensified by poultry farmers, pig farmers and other protein producers to advance the correct use of antibiotics in animal…

SANPHAR SAÚDE ANIMAL acquires IPEVE, Brazilian animal health industry, pioneer in autogenous vaccines

Belo Horizonte (MG), 15.10.2019 - SANPHAR SAÚDE ANIMAL, ERBER Group`s animal health unit, announces today the purchase of IPEVE, a Brazil-based autogenous vaccines and diagnostic services firm. The…

Close